The International Consortium for Evidence-Based Perfusion: Moving from Concept to Reality. Robert A. Baker 1, 2 , Timothy A Dickinson 2 , Donald S Likosky 2 , Kenneth G Shann 2 1 Flinders Medical Centre, Bedford Park, South Australia.
Robert A. Baker1, 2, Timothy A Dickinson2, Donald S Likosky2, Kenneth G Shann2
1Flinders Medical Centre, Bedford Park, South Australia.
2Executive, International Consortium for Evidence Based Perfusion
Pediatric Process Improvement Subcommittee
Clinically-Based Registry Subcommittee
Evidence-Based Guideline Writing Subcommittee
Scientific Sessions Subcommittee
Adult Process Improvement Subcommittee
Research Development Subcommittee
2006 Seattle, Washington (USA)
2007 Montreal, Quebec (CAN)
Dwayne Jones, CPC, CCP, RN (CAN) Moving from Concept to Reality
Christos Calaritis, BSc, CPC, CCP (CAN)
Gordon R. DeFoe, CCP
Timothy A. Dickinson, MS (Chair) (USA)
Robert C. Groom, MS, CCP (USA)
Deborah Hubble, CCP (USA)
Donald S. Likosky, PhD (USA)
Jeffrey B. Riley, MHPE, CCT (USA)
Dirck A. Rilla, LP, CCP (USA)
David J. Rosinski, CCP (USA)
Kenneth G. Shann, CCP (USA)
Alfred H. Stammers, MSA, CCP (USA)
Robert Baker, PhD, CCP (Aus)Planning Committee - 2007
Australia Moving from Concept to Reality
United StatesInternational Attendees - 2007
Bayer Pharmaceuticals Moving from Concept to Reality
The Medicines Company
CAS Medical Systems
Gish Biomedical, Inc.
Global Blood Resources
Quest Medical, Inc.
Rocky Mountain Research
Spectrum MedicalManufacturer Support - 2007
“The professions caring for patients with congenital heart disease have the unique opportunity to create the first comprehensive international database for a medical subspecialty.”
Jacobs JP. International Congenital Heart Disease Nomenclature: Introduction to Mapping and Computer Based Mapping Solutions. Presented at The International Summit on Nomenclature for Congenital Heart Disease at The Third World Congress of Pediatric Cardiology and Cardiac Surgery, Toronto, Canada, May 27, 2001.
Requirements - Accomplishments
What you Can Vary
One center’s experience
What is unique about these centers?
TAKE HOME POINTS:
The future depends on data collection, data feedback, and benchmarking
(to adjust for potential patient-level confounders)
(amend the list as the ICEBP publishes guidelines)
(among patients with normal EF)
Gordon R. DeFoe, BA, CCP
Dartmouth-Hitchcock Medical Center
Dartmouth Medical School
Lebanon, NH, USA
The Platelet Preservation Group Congenital Heart Disease
Statement: We believe that platelets are good.
NCBI - National Center For BioTechnology Information - MEDLINE search, ≥1996
((platelet OR platelets OR flow cytometry) AND (cardiac surgery OR ((("cardiopulmonary bypass"[TIAB] NOT Medline[SB]) OR "cardiopulmonary bypass"[MeSH Terms] OR ("coronary artery bypass"[TIAB] NOT Medline[SB]) OR "coronary artery bypass"[MeSH Terms]) OR (valve OR valves OR valvular) AND and surgery))) AND (biocompatible coated materials OR coated circuits)
When used in either the “tip to tip” or “all but cannula” configuration, biocompatible cardiopulmonary bypass circuits offer superior preservation and protection of platelets during and after cardiac surgery. (Class TBD, Level TBD)
Flinders Medical Centre and Flinders University, Bedford Park
* Sub group Leaders Pharmacological Intervention
Cell Salvage in the Cardiac Surgical (on pump) patient?
4 + additional
Emailed in Excel
Cell salvage is reasonable for the reduction of inflammatory markers in CS blood prior to its return to the patient. (Class TBD, Level TBD).